KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Asset Writedowns and Impairment: 2009-2019

Historic Asset Writedowns and Impairment for Quest Diagnostics (DGX) over the last 11 years, with Dec 2019 value amounting to $2.0 million.

  • Quest Diagnostics' Asset Writedowns and Impairment fell 50.00% to $2.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $11.0 million, marking a year-over-year increase of 83.33%. This contributed to the annual value of $5.0 million for FY2024, which is 400.00% up from last year.
  • According to the latest figures from Q4 2019, Quest Diagnostics' Asset Writedowns and Impairment is $2.0 million, which was down 50.00% from $4.0 million recorded in Q3 2019.
  • Quest Diagnostics' Asset Writedowns and Impairment's 5-year high stood at $86.0 million during Q1 2016, with a 5-year trough of -$235.0 million in Q4 2016.
  • For the 3-year period, Quest Diagnostics' Asset Writedowns and Impairment averaged around $2.1 million, with its median value being $2.0 million (2019).
  • As far as peak fluctuations go, Quest Diagnostics' Asset Writedowns and Impairment plummeted by 461.54% in 2016, and later soared by 133.33% in 2019.
  • Quest Diagnostics' Asset Writedowns and Impairment (Quarterly) stood at $65.0 million in 2015, then crashed by 461.54% to -$235.0 million in 2016, then skyrocketed by 101.28% to $3.0 million in 2017, then skyrocketed by 33.33% to $4.0 million in 2018, then slumped by 50.00% to $2.0 million in 2019.
  • Its Asset Writedowns and Impairment was $2.0 million in Q4 2019, compared to $4.0 million in Q3 2019 and $1.0 million in Q2 2019.